Trial Profile
Statin Therapy to Reduce the Risk of Recurrent Pancreatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Pancreatitis
- Focus Pharmacodynamics
- 17 Nov 2022 Status changed from active, no longer recruiting to completed.
- 20 Aug 2019 Planned primary completion date changed from 1 Aug 2019 to 15 Dec 2019.
- 20 Mar 2019 Status changed from recruiting to active, no longer recruiting.